Androgen deprivation for prostate cancer: the case for "first, do no harm"

Cancer. 2012 Jul 1;118(13):3232-5. doi: 10.1002/cncr.26624.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Androgen Antagonists / adverse effects*
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / surgery*
  • Venous Thrombosis / chemically induced*

Substances

  • Androgen Antagonists